申请人:US HEALTH
公开号:WO2013078413A1
公开(公告)日:2013-05-30
Disclosed are compounds of formulas I, II, and III: Formulas I, II, and III wherein R1-R19 and n are as described herein, or pharmaceutically acceptable salts thereof, or an enantiomer thereof or a conjugate thereof wherein the conjugate comprises a marker group, for use in treating or preventing a disease or disorder responsive to reduction of lipid storage droplets in an animal in need thereof. Also disclosed are pharmaceutical compositions comprising such compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and methods of treating or preventing neurodegenerative diseases and disorders.
揭示了以下公式的化合物:公式I、II和III,其中R1-R19和n如本文所述,或其药学上可接受的盐,或其对映体或其结合物,其中结合物包含一个标记基团,用于治疗或预防需要减少脂质储存滴泡的动物患有的疾病或紊乱。还揭示了包括这些化合物或其药学上可接受的盐以及药学上可接受的载体的药物组合物和治疗或预防神经退行性疾病和紊乱的方法。